Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005)
1 other identifier
interventional
615
1 country
1
Brief Summary
This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1005). It aims to evaluate the role of flexible bronchoscopy in the pre-operative workup of ground glass opacity featured lung cancer. All enrolled patients receive the flexible bronchoscopy examination before surgery. Investigators observe the intra-bronchial findings of bronchoscopy and the impact of these findings on established surgical plan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2018
CompletedFirst Posted
Study publicly available on registry
July 19, 2018
CompletedStudy Start
First participant enrolled
November 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedJuly 20, 2023
July 1, 2023
1.1 years
July 7, 2018
July 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence rate that established surgical plan is changed by positive intra-bronchial findings
The number of patients (surgical plan is changed by positive intra-bronchial findings) /Total number of patients
about 14 days
Secondary Outcomes (1)
rate of positive intra-bronchial findings
about 14 days
Study Arms (1)
Experimental:Bronchoscopy
EXPERIMENTALPatients with ground glass opacity featured lung cancer who are candidates for surgeyr received the bronchoscopy examination before surgery.
Interventions
Eligibility Criteria
You may qualify if:
- Ground glass opacity pulmonary nodule diagnosed by thoracic CT
- karnofsky performance status ≥60
- No surgical contraindication
- Patients who sign the informed consent
- Pre-operation clinical stage :T1abcN0M0
- Age:18-80 years old
You may not qualify if:
- Central lung tumor diagnosed by CT
- Tracheal or bronchus deformity diagnosed by CT
- Tracheal or bronchus disease history
- Severe smoking history (smoking index ≥400/year)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
- Henan Cancer Hospitalcollaborator
- Anhui Chest Hospitalcollaborator
- Shanghai Zhongshan Hospitalcollaborator
- Affiliated Hospital of Jiangnan Universitycollaborator
- Jilin Provincial Tumor Hospitalcollaborator
- Guanxian Central Hospital of Shandong Provincecollaborator
- The Third people's Hospital of Jieyangcollaborator
- Queen Mary Hospital, Hong Kongcollaborator
- Jiangdu people's hospital of Yangzhou Jiangsu Provincecollaborator
Study Sites (1)
Fudan University Shanghai Cancer Center
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Department of thoracic surgery and multidisciplinary group of thoracic oncology
Study Record Dates
First Submitted
July 7, 2018
First Posted
July 19, 2018
Study Start
November 6, 2018
Primary Completion
November 30, 2019
Study Completion
June 30, 2020
Last Updated
July 20, 2023
Record last verified: 2023-07